A PROSPECTIVE, NON-INTERVENTIONAL STUDY ASSESSING THE DIAGNOSTIC, THERAPEUTIC PROCEEDINGS AND SAFETY OF ANTI-HER2 TREATMENT IN ELDERLY PATIENTS (≥70 YEARS OLD) WITH HER2 POSITIVE BREAST CANCER IN ROUTINE CLINICAL PRACTICE IN POLAND -MULTICENTER, OBSERVATIONAL STUDY (HEROLD) (HerOld)

12/07/2018
02/04/2024
EU PAS number:
EUPAS24812
Study
Finalised
Documents
Study protocol
Initial protocol
English (939.38 KB - PDF) View document
Study results
Study results
English (283.49 KB - PDF) View document
Study report
Other information